http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Retinoic acid enhances lactoferrin-induced IgA responses by increasing betaglycan expression
Lee, Jeong-Min,Jang, Young-Saeng,Jin, Bo-Ra,Kim, Sun-Jin,Kim, Hyeon-Jin,Kwon, Bo-Eun,Ko, Hyun-Jeong,Yoon, Sung-il,Lee, Geun-Shik,Kim, Woan-Sub,Seo, Goo-Young,Kim, Pyeung-Hyeun CHINESE SOCIETY OF IMMUNOLOGY 2016 CELLULAR AND MOLECULAR IMMUNOLOGY Vol.13 No.6
<P>Lactoferrin (LF) and retinoic acid (RA) are enriched in colostrum, milk, and mucosal tissues. We recently showed that LF-induced IgA class switching through binding to betaglycan (transforming growth factor-beta receptor III, T beta RIII) and activation of canonical TGF-beta signaling. We investigated the combined effect of LF and RA on the overall IgA response. An increase in IgA production by LF was further augmented by RA. This combination effect was also evident in Ig germ-line alpha (GL alpha) transcription and GLa promoter activity, indicating that LF in cooperation with RA increased IgA isotype switching. We subsequently found that RA enhanced T beta RIII expression and that this increase contributed to LF-stimulated IgA production. In addition to the IgA response, LF and RA in combination also enhanced the expression of the gut-homing molecules C-C chemokine receptor 9 (CCR9) and alpha 4 beta 7 on B cells. Finally, peroral administration of LF and RA enhanced the frequency of CCR9(+)IgA(+) plasma cells in the lamina propria. Taken together, these results suggest that LF in cooperation with RA can contribute to the establishment of gut IgA responses.</P>
Bo Ra Kwon,장정민,Soo Yeon Kim,Su Hyun Lee,Soo-Yeon Kim,So Min Lee,Nariya Cho,Woo Kyung Moon 대한영상의학회 2020 Korean Journal of Radiology Vol.21 No.1
Objective: To comparatively evaluate the scan coverage and diagnostic performance of the two-view scan technique (2-VST) of the automated breast ultrasound system (ABUS) versus the conventional three-view scan technique (3-VST) in women with small breasts. Materials and Methods: Between March 2016 and May 2017, 136 asymptomatic women with small breasts (bra cup size A) suitable for 2-VST were enrolled. Subsequently, 272 breasts were subjected to bilateral whole-breast ultrasound examinations using ABUS and the hand-held ultrasound system (HHUS). During ABUS image acquisition, one breast was scanned with 2-VST, while the other breast was scanned with 3-VST. In each breast, the breast coverage and visibility of the HHUS detected lesions on ABUS were assessed. The sensitivity and specificity of ABUS were compared between 2-VST and 3-VST. Results: Among 136 breasts, eight cases of breast cancer were detected by 2-VST, and 10 cases of breast cancer were detected by 3-VST. The breast coverage was satisfactory in 94.1% and 91.9% of cases under 2-VST and 3-VST, respectively (p = 0.318). All HHUS-detected lesions were visible on the ABUS images regardless of the scan technique. The sensitivities and specificities were similar between 2-VST and 3-VST (100% [8/8] vs. 100% [10/10], and 97.7% [125/128] vs. 95.2% [120/126], respectively), with no significant difference (p > 0.05). Conclusion: 2-VST of ABUS achieved comparable scan coverage and diagnostic performance to that of conventional 3-VST in women with small breasts.
Kwon Bo Ra,Chang Jung Min,Kim Soo-Yeon,Lee Su Hyun,Shin Sung Ui,Yi Ann,Cho Nariya,Moon Woo Kyung 대한영상의학회 2020 Korean Journal of Radiology Vol.21 No.11
Objective: To compare the utility and diagnostic performance of automated breast ultrasound system (ABUS) with that of handheld ultrasound (HHUS) in evaluating pure non-mass enhancement (NME) lesions on breast magnetic resonance imaging (MRI). Materials and Methods: One hundred twenty-six consecutive MRI-visible pure NME lesions of 122 patients with breast cancer were assessed from April 2016 to March 2017. Two radiologists reviewed the preoperative breast MRI, ABUS, and HHUS images along with mammography (MG) findings. The NME correlation rate and diagnostic performance of ABUS were compared with that of HHUS, and the imaging features associated with ABUS visibility were analyzed. Results: Among 126 pure NME lesions, 100 (79.4%) were malignant and 26 (20.6%) were benign. The overall correlation rate was 87.3% (110/126) in ABUS and 92.9% (117/126) in HHUS. The sensitivity and specificity were 87% and 50% for ABUS and 92% and 42.3% for HHUS, respectively, with no significant differences (p = 0.180 and 0.727, respectively). Malignant NME was more frequently visualized than benign NME lesions on ABUS (93% vs. 65.4%, p = 0.001). Significant factors associated with the visibility of ABUS were the size of NME lesions on MRI (p < 0.001), their distribution pattern (p < 0.001), and microcalcifications on MG (p = 0.027). Conclusion: ABUS evaluation of pure NME lesions on MRI in patients with breast cancer is a useful technique with high visibility, especially in malignant lesions. The diagnostic performance of ABUS was comparable with that of conventional HHUS in evaluating NME lesions.